Skip to main content

Allopurinol News

Allopurinol May Cut Risk for Neurodegenerative Diseases

FRIDAY, May 19, 2023 – Xanthine dehydrogenase/oxidase blockers may reduce the risk for neurodegenerative diseases, according to a study published online May 17 in PLOS ONE. Yizhe Song, from the...

FDA Approves Duzallo (lesinurad and allopurinol) for Hyperuricemia in Patients with Uncontrolled Gout

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug. 21, 2017-- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced Duzallo was approved by the U.S. Food and Drug Administration (FDA) as a once-daily...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Gout, Mania

Allopurinol patient information at Drugs.com